Logo image of CHSCM

CHS INC - CHSINC 6 3/4 PERP (CHSCM) Stock Fundamental Analysis

NASDAQ:CHSCM - Nasdaq - US12542R7044 - Currency: USD

25.32  +0.03 (+0.12%)

After market: 25.54 +0.22 (+0.87%)

Fundamental Rating

4

Overall CHSCM gets a fundamental rating of 4 out of 10. We evaluated CHSCM against 91 industry peers in the Food Products industry. CHSCM has an average financial health and profitability rating. CHSCM does not seem to be growing, but still is valued expensively. Finally CHSCM also has an excellent dividend rating. With these ratings, CHSCM could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHSCM had a positive cash flow from operations.
In the past 5 years CHSCM has always been profitable.
Each year in the past 5 years CHSCM had a positive operating cash flow.
CHSCM Yearly Net Income VS EBIT VS OCF VS FCFCHSCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

CHSCM has a better Return On Assets (7.92%) than 84.71% of its industry peers.
With a decent Return On Equity value of 14.11%, CHSCM is doing good in the industry, outperforming 75.29% of the companies in the same industry.
CHSCM has a Return On Invested Capital (5.88%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CHSCM is below the industry average of 9.02%.
The last Return On Invested Capital (5.88%) for CHSCM is above the 3 year average (5.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCM Yearly ROA, ROE, ROICCHSCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

CHSCM's Profit Margin of 3.62% is in line compared to the rest of the industry. CHSCM outperforms 57.65% of its industry peers.
In the last couple of years the Profit Margin of CHSCM has grown nicely.
CHSCM has a Operating Margin (2.42%) which is comparable to the rest of the industry.
CHSCM's Operating Margin has improved in the last couple of years.
CHSCM's Gross Margin of 5.06% is on the low side compared to the rest of the industry. CHSCM is outperformed by 82.35% of its industry peers.
In the last couple of years the Gross Margin of CHSCM has grown nicely.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCM Yearly Profit, Operating, Gross MarginsCHSCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCM is creating some value.
CHSCM has a better debt/assets ratio than last year.
CHSCM Yearly Shares OutstandingCHSCM Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCM Yearly Total Debt VS Total AssetsCHSCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.82 indicates that CHSCM is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.82, CHSCM is doing good in the industry, outperforming 63.53% of the companies in the same industry.
The Debt to FCF ratio of CHSCM is 1.02, which is an excellent value as it means it would take CHSCM, only 1.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.02, CHSCM belongs to the best of the industry, outperforming 87.06% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHSCM is not too dependend on debt financing.
CHSCM has a Debt to Equity ratio of 0.19. This is in the better half of the industry: CHSCM outperforms 68.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.02
WACC5.75%
CHSCM Yearly LT Debt VS Equity VS FCFCHSCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.58 indicates that CHSCM should not have too much problems paying its short term obligations.
CHSCM has a Current ratio (1.58) which is comparable to the rest of the industry.
CHSCM has a Quick Ratio of 1.58. This is a bad value and indicates that CHSCM is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCM has a Quick ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCM Yearly Current Assets VS Current LiabilitesCHSCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

Looking at the last year, CHSCM shows a very negative growth in Revenue. The Revenue has decreased by -17.09% in the last year.
CHSCM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.88% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCM Yearly Revenue VS EstimatesCHSCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B
CHSCM Yearly EPS VS EstimatesCHSCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCM Price Earnings VS Forward Price EarningsCHSCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCM is valued cheaper than 97.65% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHSCM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.96
CHSCM Per share dataCHSCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

The decent profitability rating of CHSCM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.08%, CHSCM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.94, CHSCM pays a better dividend. On top of this CHSCM pays more dividend than 92.94% of the companies listed in the same industry.
CHSCM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 7.08%

5.2 History

The dividend of CHSCM has a limited annual growth rate of 0.78%.
CHSCM has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.78%
Div Incr Years0
Div Non Decr Years2
CHSCM Yearly Dividends per shareCHSCM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCM pays out 11.11% of its income as dividend. This is a sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCM Yearly Income VS Free CF VS DividendCHSCM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCM Dividend Payout.CHSCM Dividend Payout, showing the Payout Ratio.CHSCM Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 6 3/4 PERP

NASDAQ:CHSCM (2/21/2025, 8:08:48 PM)

After market: 25.54 +0.22 (+0.87%)

25.32

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-08 2025-01-08
Earnings (Next)04-01 2025-04-01
Inst Owners13.8%
Inst Owner Change-19.94%
Ins Owners0.03%
Ins Owner Change0%
Market Cap310.68M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield 7.08%
Yearly Dividend2.04
Dividend Growth(5Y)0.78%
DP11.11%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-17 2025-03-17 (0.421875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B 0.03
P/tB 0.03
EV/EBITDA 0.96
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY706.88%
OCF(TTM)233.94
OCFY923.92%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.75%
ROIC/WACC1.02
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%